Long-Term Cause-Specific Survival and Late Recurrence in Thymoma: A Provincial Cohort Study

Authors:

Abstract
Introduction. Thymoma is a slow-growing mediastinal tumour that can recur more than a decade after resection, and prolonged survival makes competing causes of mortality clinically important. We characterized long-term outcomes in a provincial cohort.Methods. Patients with thymoma diagnosed in British Columbia during 1999–2017 were identified through the provincial cancer registry. Overall survival (OS) was estimated by Kaplan-Meier and cumulative incidences of thymoma-related death, other-cause death, and recurrence by Aalen-Johansen methods. Cause of death was unrecorded in 29 of 79 deaths (36.7%); an observed-rate stochastic imputation model and extreme-bound sensitivity analyses were performed.Results. Of 319 thymoma cases, 238 (74.6%) had records permitting reliable abstraction. Median follow-up was 8.7 years. At 10 years, OS was 72.2% and cause-specific survival was 88.1%, a difference of 15.9 percentage points; cumulative incidences of thymoma-related and other-cause death were 10.9% and 16.9%. Among 145 R0-resected patients, 10-year cumulative incidence of recurrence was 11.9%. Across all 31 recurrences, irrespective of resection margin, 11 (35.5%) occurred after 5 years and 5 (16.1%) after 10 years; median post-recurrence survival was 122.2 months.Conclusions. Missing cause-of-death data introduce uncertainty, but thymoma-related mortality was lower than other-cause mortality. The cause-specific survival–OS gap informs counseling and adjuvant treatment decisions. Recurrence after R0 resection was uncommon; recurrence was often late and post-recurrence survival prolonged. Late recurrence is consistent with National Comprehensive Cancer Network recommendations for CT surveillance through 10 years and supports consideration of longer follow-up for selected patients.